A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2011
03/10/2011	US20110059085 Staphylococcus aureus-specific antibody preparations
03/10/2011	US20110059079 Antibody Coformulations
03/10/2011	US20110059073 Method for treating infectious disease using monoclonal antibodies
03/10/2011	US20110059072 Method for treating cancer using monoclonal antibodies
03/10/2011	US20110059071 Use of cd28-specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections
03/10/2011	US20110059068 Polypeptides involved in immune response
03/10/2011	US20110059067 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
03/10/2011	US20110059062 Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages
03/10/2011	US20110059060 Thuricin cd, an antimicrobial for specifically targeting clostridium difficile
03/10/2011	US20110059058 Strain of Lactobacillus Rhamnosus
03/10/2011	US20110059047 Novel macrocyclic inhibitors of hepatitis c virus replication
03/10/2011	US20110059043 Chemical compounds
03/10/2011	US20110059042 Substituted il-15
03/10/2011	US20110059041 Vaccine for treatment and prevention of herpes simplex virus infection
03/10/2011	US20110059040 Compositions and methods for inhibiting viral and bacterial activity
03/10/2011	US20110059039 Use of peo-pbo block copolymers in ophthalmic compositions
03/10/2011	US20110059028 Method for membrane electrolysis and the use of the products obtained by it
03/10/2011	US20110059021 Process for preparing variant of erysipelothrix rhusiopathiae surface protective antigen in e. coli
03/10/2011	US20110059015 Vaccine
03/10/2011	US20110059012 Identification of cd8+ t cells that are cd161hi and/or il18r (alpha) hi and have rapid drug efflux capacity
03/10/2011	CA2806559A1 Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
03/10/2011	CA2772875A1 Methods of treating orthomyxoviral infections
03/10/2011	CA2772813A1 Iminosugars and methods of treating filoviral diseases
03/10/2011	CA2772807A1 Methods of treating poxviral infections
03/10/2011	CA2772742A1 Antibiotic compounds
03/10/2011	CA2772484A1 Bis-benzimidazole derivatives
03/10/2011	CA2772198A1 Picrorhiza kurroa extract for prevention, elimination and treatment of rna viruses and infection or diseases caused by the same in humans, animals and in biotech industry
03/10/2011	CA2772042A1 Antimicrobial medical dressings and protecting wounds and catheter sites
03/10/2011	CA2771900A1 Tumoricidal, bactericidal, or viricidal macrophage activation
03/10/2011	CA2771327A1 Chemical compounds
03/10/2011	CA2770741A1 Novel antibacterial hydroxyphenyl compound
03/09/2011	EP2292772A1 HIV vaccination with a DNA encoding a HIV polypeptide and a HIV polypeptide
03/09/2011	EP2292771A2 Sense mRNA therapy
03/09/2011	EP2292665A1 Use of interleukin-4 antagonists and compositions thereof
03/09/2011	EP2292663A2 Antagonistic human light-specific human monoclonal antibodies
03/09/2011	EP2292658A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases
03/09/2011	EP2292652A2 Interferons uses and compositions related thereto
03/09/2011	EP2292642A1 Immunomodulating compositions, uses therefor and processes for their production
03/09/2011	EP2292632A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
03/09/2011	EP2292630A1 O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates
03/09/2011	EP2292590A2 Prodrugs of 9-aminomethyl tetracycline compounds
03/09/2011	EP2292275A2 Protecting therapeutic compositions from host-mediated inactivation
03/09/2011	EP2292273A2 Remodeling and glycoconjugation of peptides
03/09/2011	EP2292271A2 Remodelling and glycoconjugation of an antibody
03/09/2011	EP2292263A2 Compositions and methods for stabilizing biological molecules upon lyophilization
03/09/2011	EP2292261A1 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
03/09/2011	EP2292232A1 Beta-amino tetrahydroimidazo(1,2-A)pyrazines and tetrahydrotriazolo(4,3-A)pyrazines for use in the treatment of diabetes type II
03/09/2011	EP2292097A2 Recombinant parainfluenza virus expression systems and vaccines
03/09/2011	EP2291377A1 Imidazopyrimidinones and uses thereof
03/09/2011	EP2291196A2 Staphylococcus aureus-specific antibody preparations
03/09/2011	EP2291195A1 Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus
03/09/2011	EP2291188A2 Compositions and methods to protect cells by blocking entry of pathogen proteins
03/09/2011	EP2291184A2 Antiviral drugs for treatment of arenavirus infection
03/09/2011	EP2188280B1 Imidazopyridinones
03/09/2011	EP2144904B1 (s,r)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent
03/09/2011	EP2024375B1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
03/09/2011	EP1842857B1 Mutant interferon proteins and use thereof
03/09/2011	EP1840129B1 Imidazothiazole derivative and method for producing same
03/09/2011	EP1749029B1 Binding molecules capable of neutralizing rabies virus and uses thereof
03/09/2011	EP1723136B1 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
03/09/2011	EP1583558B1 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
03/09/2011	EP1364963B1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof
03/09/2011	EP1355918B1 Recombinant protective protein from $i(streptococcus pneumoniae)
03/09/2011	EP1355910B1 Formulation of boronic acid compounds
03/09/2011	EP1315513B1 "pseudo"-native chemical ligation
03/09/2011	EP1181320B1 Somatic transgene immunization and related methods
03/09/2011	EP1088098B1 Medicament for treating hiv-infected mammals
03/09/2011	EP0994949B1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
03/09/2011	CN1824255B Curcuma zedoary oil solid lipid nano-particle and its preparation method
03/09/2011	CN1651395B Borneol fatly acid ester derivative and preparation containing said derivative
03/09/2011	CN101984061A Vaccine strains of infectious clones of porcine reproductive and respiratory syndrome virus (PRRSV) and application thereof
03/09/2011	CN101983964A Compound with antibacterial activity and antitumor activity and preparation method and applications thereof
03/09/2011	CN101983724A Rapid high-throughput screening model for antiviral drugs
03/09/2011	CN101983709A Chinese herbal medicine package for preventing influenza
03/09/2011	CN101983707A Traditional Chinese medicine composition for treating children influenza and preparation method thereof
03/09/2011	CN101983669A Shiqi exogenous traditional Chinese medicine syrup
03/09/2011	CN101983668A Shiqi exogenous traditional Chinese medicine tablet
03/09/2011	CN101983667A Shiqi exogenous traditional Chinese medicine beverage
03/09/2011	CN101983665A Traditional Chinese medicine for preventing swine influenza
03/09/2011	CN101983632A Compound Tilmicosin nanoemulsion antibacterial agent and preparation method thereof
03/09/2011	CN101983631A Composition for treating infection of pseudomonas aeruginosa in chicken and preparation method thereof
03/09/2011	CN101983630A Composition for treating salpingitis of birds and preparation method thereof
03/09/2011	CN101983629A Piperacillin sodium and sulbactam sodium drug composite microsphere injection
03/09/2011	CN101983628A Mezlocillin sodium and sulbactam sodium drug composite microsphere injection
03/09/2011	CN101513409B Pharmaceutical composition of cephalexin
03/09/2011	CN101444510B Pharmaceutical preparation containing voriconazole and preparation method thereof
03/09/2011	CN101418005B Novel method for synthesizing prulifloxacin
03/09/2011	CN101309677B Cleaner for precaution against of cow's hoof, manufacturing method thereof, and using method thereof
03/09/2011	CN101284009B Cefoperazone sodium and sulbactam sodium combination and preparation method thereof
03/09/2011	CN101228180B Tripeptides as hepatitis C virus inhibitors
03/09/2011	CN101068560B Method of screening toxin-neutralizing peptide, STX2 inhibitory peptide and Vero toxin-neutralizing agent
03/08/2011	US7902366 NK1 antagonists
03/08/2011	US7902360 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility
03/08/2011	US7902349 Nucleic acids encoding protective epitopes of adenyl cyclase-haemolysin (AC-Hly)
03/08/2011	US7902261 Use of fingolimod or salt
03/08/2011	US7902253 Isoflavone derivatives of tectorigenin, the preparation thereof and the antiviral medicine containing the same as an effective constituent
03/08/2011	US7902185 Treatment of neurodegenerative diseases using proteasome modulators
03/08/2011	US7902182 HIV integrase inhibitors
03/08/2011	US7902179 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease
03/08/2011	US7902170 Influenza virus binding, sialylated oligosaccharide substance and use thereof

1 ... 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 ... 1798